Knight Therapeutics | GUD - PE Price to Earnings

Stock Price
8.43
Daily Change
-0.21 -2.43%
Monthly
9.91%
Yearly
45.34%
Q2 Forecast
8.25

Knight Therapeutics reported 257.34 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acasti Pharma 9.94 0.08 Mar/2021
Akebia Therapeutics 1.63K 1.6K Dec/2025
Aurora Cannabis 23.27 0 Sep/2025
Cronos Group 23.89 2.52 Dec/2025
Dianthus Therapeutics 3.8 1.53 Sep/2024
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 19.37 7.21 Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Moderna 27.22 14.51 Jun/2023
Organigram Holdings 235 224.49 Sep/2025
Organon & Co 3.75 0.87 Dec/2025
Revvity 30.79 19.08 Mar/2026
Tectonic Therapeutic 4.01 0.63 Mar/2024
Tilray 11.56 80.19 Sep/2025
Viatris 14.61 4.21 Mar/2026